REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 13th, 2022 • Marker Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 13th, 2022 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of December 12, 2022, is entered into by and between MARKER THERAPEUTICS, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
PURCHASE AGREEMENTPurchase Agreement • December 13th, 2022 • Marker Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 13th, 2022 Company Industry JurisdictionTHIS PURCHASE AGREEMENT (the "Agreement"), dated as of December 12, 2022, is made by and between MARKER THERAPEUTICS, INC., a Delaware corporation (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the "Investor").